Published in Eur Radiol on December 11, 2007
Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol (2009) 1.04
Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol (2011) 0.97
Natural history of small renal masses. Chin Med J (Engl) (2015) 0.78
Growth Pattern of Clear Cell Renal Cell Carcinoma in Patients with Delayed Surgical Intervention: Fast Growth Rate Correlates with High Grade and May Result in Poor Prognosis. Biomed Res Int (2015) 0.77
The growth rate of "clinically significant" renal cancer. Springerplus (2015) 0.75
Renal Cell Carcinoma in a Pregnant Woman With Horseshoe Kidney. Urol Case Rep (2017) 0.75
Natural history of renal cell carcinoma: a case with 18 years follow-up. Clin Exp Nephrol (2010) 0.75
Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease. Eur Radiol (2015) 0.75
Analysis of serial measurements in medical research. BMJ (1990) 16.69
Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol (1982) 8.47
The changing natural history of renal cell carcinoma. J Urol (2001) 4.72
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol (2006) 3.88
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
A biomathematical approach to clinical tumor growth. Cancer (1962) 3.10
Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology (2000) 2.72
The natural history of incidentally detected small renal masses. Cancer (2004) 2.57
Small renal parenchymal neoplasms: further observations on growth. Radiology (1995) 2.15
Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol (1999) 1.84
Volume determinations using computed tomography. AJR Am J Roentgenol (1982) 1.55
Natural history of renal masses followed expectantly. J Urol (2004) 1.51
Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol (2004) 1.20
The natural history of small renal masses. J Urol (2000) 1.19
Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology (2002) 1.14
Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol (2001) 1.13
Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol (2004) 1.10
The natural history of small renal masses. Nat Clin Pract Urol (2005) 0.86
Observations on the growth of renal neoplasms. Radiology (1990) 0.85
Renal cell carcinoma in acquired cystic kidney disease: volume growth rate determined by helical computed tomography. Am J Kidney Dis (2000) 0.76
The natural history of incidentally detected small renal masses. Cancer (2004) 0.75
Growth of renal masses. Radiology (1996) 0.75
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology (2012) 2.36
Gossypiboma in abdomen and pelvis: MRI findings in four patients. AJR Am J Roentgenol (2007) 2.19
Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol (2009) 1.89
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol (2005) 1.57
Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol (2007) 1.57
Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists. J Gastroenterol Hepatol (2009) 1.53
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology (2012) 1.52
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol (2010) 1.51
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol (2012) 1.47
The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol (2010) 1.45
Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer. J Comput Assist Tomogr (2007) 1.44
Changes in the signal- and contrast-to-noise ratios of hepatocellular carcinomas on gadoxetic acid-enhanced dynamic MR imaging. Eur J Radiol (2012) 1.42
Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T. Korean J Radiol (2012) 1.33
Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr (2005) 1.29
Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol (2008) 1.22
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. J Korean Med Sci (2010) 1.21
Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol (2008) 1.20
Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol (2006) 1.19
Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. AJR Am J Roentgenol (2010) 1.18
High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol (2010) 1.17
Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging (2009) 1.17
Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics (2011) 1.17
Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol (2008) 1.17
Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol (2009) 1.16
Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features. Radiographics (2007) 1.15
Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol (2008) 1.15
The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol (2010) 1.15
Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology (2012) 1.14
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. Cancer Res Treat (2012) 1.14
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol (2012) 1.11
MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol (2008) 1.07
Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr (2007) 1.07
Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics (2008) 1.07
Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: evaluation of doubling time, frequency, and features on CT. AJR Am J Roentgenol (2005) 1.06
Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol (2011) 1.05
Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol (2009) 1.05
Small submucosal tumors of the stomach: differentiation of gastric schwannoma from gastrointestinal stromal tumor with CT. Korean J Radiol (2012) 1.04
Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol (2009) 1.04
Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol (2005) 1.04
Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging. J Magn Reson Imaging (2012) 1.04
Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch (2008) 1.04
Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol (2012) 1.03
Preoperative staging of rectal cancer: comparison of 3-T high-field MRI and endorectal sonography. AJR Am J Roentgenol (2006) 1.02
What is the complementary role of ultrasound evaluation in the diagnosis of acute appendicitis after CT? Eur J Radiol (2009) 1.02
Recurrence of retroperitoneal liposarcoma: imaging findings and growth rates at follow-up CT. AJR Am J Roentgenol (2008) 1.02
Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol (2002) 1.01
Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol (2006) 1.01
Correlation between sonographic findings and infection intensity in clonorchiasis. Am J Trop Med Hyg (2005) 0.99
Gastric cancer staging at isotropic MDCT including coronal and sagittal MPR images: endoscopically diagnosed early vs. advanced gastric cancer. Abdom Imaging (2009) 0.99
A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique. J Vasc Interv Radiol (2011) 0.99
Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol (2008) 0.98
Gastric cancer: imaging and staging with MDCT based on the 7th AJCC guidelines. Abdom Imaging (2012) 0.98
Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. AJR Am J Roentgenol (2010) 0.98
The role of endorectal magnetic resonance imaging in predicting extraprostatic extension and seminal vesicle invasion in clinically localized prostate cancer. Korean J Urol (2010) 0.98
High-intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol (2008) 0.98
Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy. AJR Am J Roentgenol (2014) 0.97
Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging (2008) 0.97
Radiofrequency ablation of rabbit liver in vivo: effect of the pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J Radiol (2005) 0.97
Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations. Korean J Radiol (2013) 0.94
Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol (2004) 0.94
Update of prostate magnetic resonance imaging at 3 T. J Comput Assist Tomogr (2008) 0.94
Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance. Eur Radiol (2015) 0.94
Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol (2009) 0.93
Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function. NMR Biomed (2011) 0.93
Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes. Radiology (2015) 0.93
Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol (2006) 0.93
The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiol (2013) 0.93
Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr (2004) 0.92
Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI. AJR Am J Roentgenol (2014) 0.92
Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology (2003) 0.92
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol (2012) 0.92
Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock. Abdom Imaging (2015) 0.92
Utility of iodine overlay technique and virtual unenhanced images for the characterization of renal masses by dual-energy CT. AJR Am J Roentgenol (2011) 0.91
Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US. Korean J Radiol (2003) 0.91
Differentiation of an intrapancreatic accessory spleen from a small (<3-cm) solid pancreatic tumor: value of diffusion-weighted MR imaging. Radiology (2012) 0.91
Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol (2009) 0.91
Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol (2005) 0.91
Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg (2010) 0.91
Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol (2010) 0.90
Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience. Korean J Radiol (2010) 0.90
Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci (2007) 0.90
Renal infarction resulting from segmental arterial injury during radiofrequency ablation of renal tumor in patient with a single kidney. Urology (2008) 0.90
Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session. J Ultrasound Med (2011) 0.90
Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology (2014) 0.89
Diagnostic performance of CT in the detection of intestinal ischemia associated with small-bowel obstruction using maximal attenuation of region of interest. AJR Am J Roentgenol (2010) 0.89